Speech-Language Pathologists in Wheelwright, KY Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Leigh Ann Thornsberry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1031 Ky Route 306, Wheelwright, KY 41669 Phone: 859-358-7891 |
News Archive
UH researcher investigates two new avenues for detection, treatment of prostate cancer
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer-related deaths among men in the U.S. The challenge with prostate cancer is that the standard treatment methods in the advanced stage of the disease lose effectiveness after about one to two years, leading to recurrence and, ultimately, death. A University of Houston researcher and his team are working to change that.
Caliper Life Sciences introduces automated nucleic acid fractionation instrument, LabChip XT
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced the LabChip XT, an automated nucleic acid fractionation instrument.
SARS-CoV-2 RNA in blood tests not associated with infectious virus
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has challenged hospitals and laboratory services worldwide. Diagnostic testing for SARS-CoV-2 initially lagged but is now primarily based on the use of reverse transcriptase-polymerase chain reaction (RT-PCR) to detect viral nucleic RNA in the samples. However, viral RNA has also been reported in several small series of cases, though its significance and frequency remain unclear.
UNH receives $2.97 million in grants to investigate the effectiveness of wilderness therapy
The University of New Hampshire's Outdoor Behavioral Healthcare Center receives $2.97 million in grants to conduct a first-of-its-kind randomized study looking at the effectiveness of outdoor behavioral health (OBH), or wilderness therapy, a prescriptive treatment for teens struggling with depression, anxiety and substance use disorders.
Abbott commences elagolix Phase 3 trial in endometriosis
Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.
› Verified 1 days ago